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UBXThe AAA protein p97 is a central component in the ubiquitin–proteasome system, in which it is thought to act
as a molecular chaperone, guiding protein substrates to the 26S proteasome for degradation. This function is
dependent on association with cofactors that are speciﬁc to the different biological pathways p97 participates
in. The UBX-protein family (ubiquitin regulatory X) constitutes the largest known group of p97 cofactors. We
propose that the regulation of p97 by UBX-proteins utilizes conserved structural features of this family. First-
ly, they act as scaffolding subunits in p97-containing multiprotein complexes, by providing additional inter-
action motifs. Secondly, they provide regulation of multiprotein complex assembly and we suggest two
possible models for p97 substrate recruitment in the UPS pathway. Lastly, they impose constraints on p97
and its interaction with substrates and further cofactors. These features allow the regulation, within the
UPS, of the competitive interactions on p97, a regulation that is crucial to allow the diverse functionality of
p97. This article is part of a Special Issue entitled: AAA ATPases: structure and function., ATPase associated with vari-
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The metazoan protein p97, also known as VCP (Valosin containing
protein), is a highly conserved type II AAA protein containing two
AAA ATPase domains [1–3]. The ATPase domains are commonly re-
ferred to as the D1 and D2 domains and share N40% sequence identi-
ty. In addition, p97 contains an amino-terminal N-domain and an
unstructured carboxy-terminal extension (Fig. 1A). Like many other
AAA proteins, p97 forms a stable homo-hexameric ring, which is es-
sential for both its ATPase and biological activity [4].
p97 has many roles within the cell, most of them linked to ubi-
quitin signaling or to the ubiquitin–proteasome system (UPS). It is
thought to serve as a molecular chaperone in the UPS, separating
polyubiquitylated targets from unmodiﬁed proteins and delivering
them to the 26S proteasome [5]. The best-studied roles of p97
are in endoplasmic reticulum-associated degradation and homoty-
pic membrane fusion, but the protein has also been implicated in
transcription activation, mitosis, apoptosis, as well as DNA repair
pathways [6–8]. It has also been suggested that p97 stimulatesubiquitin chain elongation, promotes deubiquitylation, or prevents
these modiﬁcations depending on association with speciﬁc cofac-
tors [9]. This is corroborated by the many indirect associations of
p97 with E3 ubiquitin ligases, which are involved in a multitude
of regulatory functions within the cell [10]. p97 may thus be in-
volved in even more aspects of the UPS than previously thought
and may also process many soluble protein substrates. The targets
of p97 can then either be recycled or degraded by the ubiquitin
proteasome pathway.
Ubiquitylation is also used as a signaling motif in an array of differ-
ent pathways that are largely unrelated to the UPS, for example re-
ceptor trafﬁcking, cell cycle control and DNA repair (reviewed in
[11]).
The astonishing diversity of p97 functions is facilitated by spe-
ciﬁc cofactors, also known as p97 adaptors, that associate with
p97 [12–20]. Many of the known p97 adaptors utilize conserved
binding motifs, with the ubiquitin-regulatory X (UBX) domain as
the most common motif [21]. This domain is conserved among a
number of p97 adaptor proteins and consists of a ubiquitin-like
fold of the form β–β–α–β–β–α–β [22]. A conserved loop between
strands 3 and 4 of the β-sheet (S3/S4 loop) inserts into a groove
in the N-domain of p97 to form a stable protein–protein interaction
[23] in the p97–p47 complex. The same loop was shown, in recent
crystal structures, to mediate the interaction between the UBX do-
main of FAF1 and the p97 N domain [24,25], though it was
reported to adopt an unusual cisPro touch-turn conformation [24].
The UBX-like (UBX-L) domain, also known as the UBD domain in
the p97 adaptor Npl4, is present in several other proteins that
have not been formally included in the UBX protein family
(Fig. 1C). It adopts a structure similar to the UBX domain but
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Fig. 1. Schematic representation of the domain architecture of p97 and the UBX protein family: The deﬁned domains of mouse (A) p97, (B) ubiquitin regulatory X (UBX) domain-
containing proteins, and (C) UBX-like (UBX-L) domain-containing proteins are shown. The protein lengths are shown, in amino acids, for each protein and the domains are labeled
and color-coded. p97 consists of a N-domain (light blue) and two AAA domains, D1 (pale yellow) and D2 (light green). The UBA (ubiquitin associating) domain (orange), found in
several UBX proteins, is located on the N-terminus. The UBX domain (green) is usually found close to the C-terminus of the proteins. The SEP (Shp, eyes-closed, p47) (red) and UAS
(ubiquitin associated) (magenta) domains are both located in the central part of those proteins they occur in. Other domains found in mouse UBX proteins are the UBX-L (teal), CC
(Coiled-Coil) regions (brown), ThF (Thioredoxin-like domain) (pink), OTU (ovarian tumor) domain (gray), and ZF (zinc-ﬁnger) (blue), as indicated. Also present are the UIM (ubi-
quitin interaction motif) (dark blue), SHP motif (yellow) and transmembrane domains (black). All schematics are shown to scale, the bar represents 100 amino acids.
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binding. However despite this, the UBX-L of Npl4 has been shown
to bind the p97 N-domain as well [26].
UBX-containing proteins are poorly characterized biochemically
and structurally, but consensus is emerging that the UBX protein fam-
ily plays a vital role as p97 adaptors. So far, 13 UBX domain-containing
proteins have been identiﬁed in mammals, all of which have been
demonstrated to bind p97 [10], conﬁrming the earlier proposal of
the UBX domain as a general p97 interaction motif [23]. The UBX
protein family act at the p97-UPS interface as scaffolding proteins for
p97-containing multiprotein complexes. These higher-order com-
plexes can involve several substrate-processing cofactors in addition
to target substrates. Furthermore, p97 is regulated by UBX proteins
through the large interaction network they create as well as the archi-
tectural restrictions they impose on p97 and its complexes. In this
review, we collate the current understanding of mammalian p97
ubiquitin-dependent processes regulated by UBX proteins and pro-
pose a mechanism for p97 recruitment and regulation within the
UPS.2. Recent advances in p97 regulation by UBX proteins
Despite similar interactions with p97, individual UBX proteins
participate in a wide variety of ubiquitin-dependent pathways
whose characterization has progressed considerably since the most
recent reviews dealing with p97 adaptors [21,27]. In this section we
summarize the UBX protein interaction network and its implications
on p97 regulation.2.1. p97-UBX multiprotein complexes
Several UBX proteins have been directly linked to the UPS and me-
diate interactions of p97 with key proteins involved in the UPS, or
with ubiquitylated substrates destined for the proteasome.
UBXD1 (UBX domain containing protein 1) and UBXD2 are not
known to bind directly to ubiquitylated substrate, but instead bind
to substrate-processing components of the UPS. In vivo, UBXD1
forms a complex with p97 and two integral ERAD components,
Hrd1 and HERP (homocysteine-responsive endoplasmic reticulum-
resident protein) [28,29]. Over-expression of UBXD1 leads to dissoci-
ation of Ufd1 from p97 and diminished degradation of ERAD sub-
strates. As important residues within the UBX consensus are not
conserved in UBXD1, the UBXD1 UBX domain is unable to bind p97
[30]. However, full-length UBXD1 can bind to the p97 C-terminus
via its central PUB domain [28,30]. This binding interaction is likely
to be similar to that seen in the crystal structure of the PNGase (pep-
tide N-glycanase) PUB (PNGase/UBA or UBX) domain in complex
with a p97 C-terminal peptide [31]. In addition, a secondary binding
site in the N-terminal part of UBXD1 interacts with the p97 N-
domain [30]. Binding of UBXD1 to p97 can coincide with binding
of p47, another UBX protein. Increasing concentrations of p47 reduce
the p97-UBXD1 association however, indicating that although they
are not mutually exclusive they do hinder rather than enhance
each other's binding [28]. UBXD1 is the only adaptor that has so far
been found to bind to both the N- and C-termini of p97. This feature
has led to the proposal that UBXD1 can either regulate the occupancy
of cofactors on p97 or remove them completely, thus acting as a
“reset button” [30].
127P. Kloppsteck et al. / Biochimica et Biophysica Acta 1823 (2012) 125–129UBXD2, also known as erasin, is also known to bind components of
the UPS. This integral membrane protein is found in the endoplasmic
reticulummembrane and in the nuclear envelope, and is linked to the
UPS via its association with Derlin-1 and gp78 in the ER membrane
[32]. The demonstration that depletion of UBXD2 inhibits ERAD
established a key role for UBXD2 in this pathway [32].
Recruitment of ubiquitylated substrates to p97 is one of the cen-
tral functions of adaptor proteins. Binding to ubiquitin chains can be
accomplished with several conserved binding motifs [33], of which
the UBA (ubiquitin associating) domain is widespread amongst UBX
proteins (Fig. 1B). The UBA domain is present in UBXD7, SAKS1
(stress activated kinase substrate 1), FAF1 (Fas associated factor 1),
p47 and UBXD8, allowing these UBX proteins to bind ubiquitylated
substrates directly. It is thus likely that these proteins play a role in
ubiquitin-dependent processes. Another UBX protein, UBXD2, does
not contain a UBA domain but is thought to form a ternary complex
with p97 and the UBA domain-containing UPS factor ubiquilin. Com-
plex formation is mediated by UBXD2 through its binding to the cen-
tral domain of ubiquilin and to the p97 N-domain [34]. UBXD2 could
thus utilize the UBA domain at the N-terminus of ubiquilin for an in-
direct interaction with ubiquitylated substrates. Similarly UBXD4
does not have a UBA domain either, but might utilize ubiquilin for
substrate interactions. Although no direct interaction of UBXD4 and
ubiquilin has been reported, both are directly involved in the regula-
tion of α3-containing nicotinic acetylcholine receptors (nAChRs) by
the proteasome [35,36]. The direct interaction of the UBXD7 UBA do-
main with its substrate HIF1α is, on the other hand, well established
[10]. UBXD7 ﬁrst binds polyubiquitylated HIF1α, which is then fol-
lowed by binding to p97 and subsequent degradation of HIF1α.
UBXD7 also interacts, directly or indirectly, with a large number of
E3 ubiquitin ligases (E3s) [10] and links p97 to these enzymes.
Other UBX proteins can similarly interact with E3s. The interaction
does not appear to be speciﬁc for individual UBX proteins and the re-
spective E3s, although a slight preference for certain E3s has been
reported [10].
SAKS1 is also thought to bind directly to substrates, in this case to
prevent their degradation [37]. SAKS1 is thought to bind preferential-
ly to polyubiquitylated substrates, hindering their deubiquitylation,
at the 26S proteasome, although the biological relevance of this is un-
known [38]. Furthermore, the p97-SAKS1 complex was found to im-
munoprecipitate the p97 C-terminal-binding adaptors PNGase and
PLAP, both of which are involved in the UPS [10,37]. This suggests
that SAKS1 can bind to p97 simultaneously with PNGase or PLAP. So
far it is unclear whether this is a unique characteristic of SAKS1 that
is relevant to its function.
Unlike most other UBX proteins, FAF1 is linked to a number of dif-
ferent pathways where p97 involvement is unclear (reviewed in
[39]). The UBA domain of FAF1 binds both Lys-48 and Lys-63 linked
polyubiquitin chains, suggesting that FAF1 has ubiquitin-dependent
roles outside proteasomal degradation [40]. FAF1 has been directly
linked to p97 regulation in the UPS. Its overexpression in mammalian
cells inhibits UPS-dependent degradation [40]. This effect was in-
creased by the expression of the isolated UBA domain, whereas over-
expression of a ΔUBA construct had no effect on protein removal. It
was thus suggested that FAF1 binds ubiquitylated UPS substrates via
the UBA domain and that p97, via the UBX domain of FAF1, mediates
substrate delivery to the proteasome for degradation.
The two UBX proteins p47 and TUG (tether containing a UBX do-
main for glucose transporter 4 (GLUT4)) have been linked to ubiqui-
tin-dependent pathways outside of the UPS. The p97–p47 complex is
involved in the process of homotypic membrane fusion to reassemble
the Golgi and ER after mitosis [13]. The UBA domain of p47 [15] and
the deubiquitylating enzyme VCIP135 [41] are essential for this path-
way, but their exact roles are unclear. The UBX protein TUG regulates
GLUT4-containing vesicles intracellularly and regulates insulin-
dependent GLUT4 turnover [42,43].2.2. Regulation of multiprotein complex assembly
As well as acting as a platform for multiprotein complexes, some
UBX proteins display differential afﬁnities for particular components
of the complexes, which may be used to control the order of recruit-
ment. For instance, the interaction of UBXD7 with ubiquitylated
HIF1α is independent of p97. Once bound to substrate, UBXD7 has
an increased afﬁnity for p97. Similarly, SAKS1 showed reduced coim-
munoprecipitation of p97 with both ubiquitin binding-deﬁcient and
ΔUBA constructs [38]. Additionally, increased levels of polyubiquity-
lated protein in cells correlate with an increased amount of SAKS1
bound to p97 [37]. These observations suggest that p97 is recruited
to some UBX proteins only in the presence of ubiquitylated substrate.
In contrast, p47 shows a different behavior. The p97–p47 complex
binds signiﬁcantly better to Ub-GST in pull-down experiments than
p97 or p47 alone. It was noted that p97 is recruited to p47 prior to
substrate binding [15]. Such changes in the substrate afﬁnity provide
opportunities for regulation in the sequence of complex formation
and may be a crucial factor in global p97 regulation.
Based on analysis of the p97–UBXD7, p97–SAKS1 and p97–p47
complexes we can conclude that a single model for the assembly of
p97-containing multiprotein complexes is insufﬁcient. Depending
on the speciﬁc pathway, different modes of control appear to be in
use. We propose two distinct models for sequential p97/substrate
complex formation under the control of UBX proteins (Fig. 2), with
the possibility of further differentiation depending on other cofactors.
The ﬁrst mode of complex assembly starts with binding of the
adaptor protein to ubiquitylated substrate. The adaptor–substrate
complex then recruits p97. This is the case for UBXD7 and SAKS1,
where p97 activity is thus regulated by the availability of substrate.
The chosen biological process, be it degradation or other pathways,
is set in motion by substrate ubiquitylation. Binding of the ubiquity-
lated substrate to the adaptor protein could induce a conformational
change in the adaptor protein that increases its afﬁnity for p97. p97
and other cofactors that might be necessary are then recruited, and
the complex is poised towards its functional outcome.
In the second mode of regulation, binding of the UBX-protein
adaptor to p97 creates a complex that is competent to interact with
substrate. One example is p47. Here, regulation happens when the
adaptor protein, whose availability is perhaps limited through differ-
ential cell localization, tissue-speciﬁc expression changes or post-
translational modiﬁcations, becomes accessible to p97. The p97-
adaptor complex then has increased afﬁnity for the ubiquitylated
substrate or other cofactors and is recruited as a complex for the re-
quired role.
3. Architectural constraints imposed on p97 by conserved UBX
protein features
Several structural features are recurrent in UBX proteins that are
not necessarily conserved in sequence, but are likely to be relevant
for their function in p97 complexes. These features include the con-
servation of distinct domain arrangements, prevalence of a second
p97 binding site and a propensity for oligomerization. These structur-
al features impose architectural constraints on p97, decreasing its
ﬂexibility and mediating binding of other adaptors to p97.
The UBA domain is present in many UBX proteins and its arrange-
ment, with respect to the UBX domain, is conserved within the UBX
family. The UBA domains of FAF1, SAKS1, p47, UBXD7 and UBXD8
are close to the amino-terminus, which leaves the majority of the
protein as a potential ‘linking’ region between the two domains.
This provides the possibility of attaching further cofactors and sub-
strate in a spatially constrained manner in relation to p97. The con-
served domains within the UBX protein family also distinguish the
UBX protein family from proteins containing a UBX-L domain
(Fig. 1C). The UBX-L domain is likely to employ a mechanism of p97
AB
p97
Ub Ub Ub Ub
Ub Ub Ub Ub
Ub Ub Ub Ub
p97
Ub Ub Ub Ub
p97
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Fig. 2. The observed modes of p97 substrate recruitment in the UPS. Based on the behavior of UBA-containing UBX proteins, two models of p97-UBX protein-substrate recruitment
are proposed. These may involve binding to p97 alone or a p97 core complex (gray), such as the p97/Ufd1/Npl4 complex, that can bind simultaneously with several UBX proteins
[10]. (A) The UBX protein, containing a UBX and UBA domain, binds ubiquitylated substrate (black) via the UBA domain. The UBX-UBA/substrate complex has an increased afﬁnity
for p97 or the p97 core complex (gray), such that the adaptor-substrate complex recruits p97 and is initiated into the UPS. (B) An alternative model for p97 substrate recruitment
through UBX protein binding is that binding of the UBX protein to p97 or the p97 core complex induces an increase in afﬁnity of the UBX protein to the substrate, recruiting the
ubiquitylated substrate to the UPS.
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exhibit any of the aforementioned structural features of the UBX pro-
tein family and should thus either be treated separately from UBX
proteins or classiﬁed as a distinct subfamily [26].
At least 6 mammalian UBX proteins contain a second p97 inter-
action site outside the UBX domain, and two may even have a
third. The SEP domain-containing UBX proteins p37, p47, UBXD4
and UBXD5, and also TUG, contain the SHP box, a short motif
known to interact with the p97 N-domain [17,21,23]. The SHP
motif is located N-terminal of the UBX domain, connected via a
mainly unstructured linker. Besides the SHP box, TUG also contains
a UBX-L domain, which can potentially bind p97, although this in-
teraction has not yet been conﬁrmed. UBXD1, whose UBX domain
has not yet been conﬁrmed to bind to p97 (see above), is also
thought to contain two p97 binding sites: a PUB domain and a sec-
ond low-afﬁnity binding site.
The two separate p97 binding sites on these proteins would im-
pose steric constraints on p97. For example, simultaneous binding
of two connected domains to p97 might decrease the conformational
ﬂexibility of p97 or orient the adaptor in a way that may be essential
for the speciﬁc function or required for binding of further cofactors or
substrate. A similar effect could occur when a UBX protein forms a
homo-oligomer. The only UBX protein known to do this is p47 [44].
The oligomeric state of other UBX proteins has not yet been studied
rigorously. Oligomerization of p47 is mediated through its SEP do-
main, a structural feature that also occurs in p37, UBXD4 and
UBXD5, suggesting that these proteins can also form oligomers.
Apart from these SEP domain-containing UBX proteins, FAF1, SAKS1,
UBXD2 and UBXD5 contain predicted coiled-coil regions (according
to the Multicoil algorithm at http://groups.csail.mit.edu/) that could
promote oligomer formation. Whether the SEP domains or coiled-
coils facilitate homo-oligomerization in UBX proteins that contain
them awaits experimental conﬁrmation. But it is tempting to specu-
late that p47 is not the only UBX family protein that regulates p97
function by exploiting the restraints of multiple binding sites. In addi-
tion, the larger size of oligomers with respect to monomers couldrestrict the number of different adaptors bound to a single p97 hex-
amer and provide yet another level of regulation.
The combination of these architectural features would impose
several steric constraints on the quaternary structure of p97 multi-
protein complexes. This allows UBX proteins to mediate the spatial
arrangement of p97 complexes, orienting themselves, additional co-
factors and substrates as required for the speciﬁc function and may
also prevent the binding of unnecessary cofactors or cofactors detri-
mental to the speciﬁc process to p97 or the complex. Oligomerization
of the UBX proteins would additionally have the effect of increasing
the afﬁnity to p97, other cofactors or to substrate, through avidity.
This could be particularly important in the binding of UBA domains
to polyubiquitin as different spatial arrangements provide a number
of possible ubiquitin binding sites.
The arrangement of the p97/substrate complexes is especially im-
portant for the mechanism of mechanical force transmission from
p97 to its substrates. The function of some adaptors might be nothing
more than presenting the substrate to p97 in a spatially controlled
manner. Other adaptors might act as levers that transmit the confor-
mational change caused in p97 by ATP hydrolysis to the substrate.
This function would absolutely require an ordered quaternary com-
plex. The negative effect of p47 on p97 ATPase activity [45] might
be due to the restrictive effect of the p47 trimer on an otherwise ﬂex-
ible p97 ring, which may also reduce the conformational ﬂexibility of
the p97 N-domain. It was recently shown that the N-domain can
adopt a conformation on top of the D1 ring instead of on the side of
D1 [46]. This conformational change may either affect adaptor bind-
ing or is affected by adaptor binding to p97, which would in turn ex-
plain the ATPase inhibiting effect of p47.
4. Conclusion
The details of p97-containing complexes in distinct cellular path-
ways suggest a complex regulatory network acting on p97 function
in ubiquitin-dependent processes. The features displayed by UBX pro-
teins suggest that these proteins regulate an important subset of the
129P. Kloppsteck et al. / Biochimica et Biophysica Acta 1823 (2012) 125–129p97 interaction network within the UPS and directly affect the se-
quential formation of p97 substrate-processing complexes. They are
themselves regulated to reduce the number of competitive interac-
tions on p97 at any particular location within the cell. They also act
as scaffolding proteins for p97 multiprotein complexes that can inﬂu-
ence the spatial arrangement of p97 complexes to facilitate correct
orientation for substrate binding and subsequent processing, to en-
able the diverse functionality of p97. The regulation of p97 at the in-
terface of the UPS by UBX proteins provides control of p97 availability
to the cell, which is essential for its participation in such a wide vari-
ety of cellular functions.
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